Activation of large-conductance, Ca2+-activated K+ channels by cannabinoids

American Journal of Physiology - Cell Physiology

Volumn 290, Issue 1, 2006, Pages

  Sade, Hiroko ^a   Muraki, Katsuhiko ^a   Ohya, Susumu ^a   Hatano, Noriyuki ^a   Imaizumi, Yuji ^a  

^a NAGOYA CITY UNIVERSITY   (Japan)

Author keywords

Anandamide; Channel opener

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANANDAMIDE; CALCIUM; CALCIUM ACTIVATED POTASSIUM CHANNEL; CANNABINOID; CANNABINOID RECEPTOR AGONIST; CANNABINOID RECEPTOR ANTAGONIST; KT 5823; METHANANDAMIDE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; N (6 AMINOHEXYL) 5 CHLORO 1 NAPHTHALENESULFONAMIDE; UNCLASSIFIED DRUG; AMIDE; ARACHIDONIC ACID DERIVATIVE; ENDOCANNABINOID; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; PROTEIN SUBUNIT;

ARTICLE; CALCIUM CELL LEVEL; CELL STRAIN HEK293; CONTROLLED STUDY; CYTOPLASM; DRUG EFFECT; DRUG POTENTIATION; HUMAN; HUMAN CELL; MUSCLE CELL; PATCH CLAMP; PRIORITY JOURNAL; VOLTAGE CLAMP; ANIMAL; BAGG ALBINO MOUSE; CELL LINE; CELL MEMBRANE POTENTIAL; CHANNEL GATING; CYTOLOGY; GENETICS; KIDNEY; MALE; METABOLISM; MOUSE; MUTAGENESIS; PHYSIOLOGY; THORACIC AORTA; VASCULAR SMOOTH MUSCLE;

ANIMALS; AORTA, THORACIC; ARACHIDONIC ACIDS; CELL LINE; ENDOCANNABINOIDS; HUMANS; ION CHANNEL GATING; KIDNEY; LARGE-CONDUCTANCE CALCIUM-ACTIVATED POTASSIUM CHANNELS; MALE; MEMBRANE POTENTIALS; MICE; MICE, INBRED BALB C; MUSCLE, SMOOTH, VASCULAR; MUTAGENESIS; PATCH-CLAMP TECHNIQUES; POLYUNSATURATED ALKAMIDES; PROTEIN SUBUNITS;

EID: 33644820331     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00482.2004     Document Type: Article

References (49)

1. Abadji V, Lin S, Taha G, Griffin G, Stevenson LA, Pertwee RG, and Makriyannis A. (R)-methanandamide: a chiral novel anandamide possessing higher potency and metabolic stability. J Med Chem 37: 1889-1893, 1994.
2. + current. J Biol Chem 278: 46188-46194, 2003.
3. Behrens R, Nolting A, Reimann F, Schwarz M, Waldschütz R, and Pongs O. hKCNMB3 and hKCNMB4, cloning and characterization of two members of the large-conductance calcium-activated potassium channel β subunit family. FEBS Lett 474: 99-106, 2000.
4. 1 subunit of the calcium-activated potassium channel. Nature 407: 870-876, 2000.
5. Chemin J, Monteil A, Perez-Reyes E, Nargeot J, and Lory P. Direct inhibition of T-type calcium channels by the endogenous cannabinoid anandamide. EMBO J 20: 7033-7040, 2001.
6. Ca channel activity by fatty acids: structural requirements and mechanism of action. Am J Physiol Cell Physiol 283: C1441-C1453, 2002.
7. 2+ sensitivity. J Gen Physiol 116: 411-432, 2000.
8. De Petrocellis L, Cascio MG, and Di Marzo V. The endocannabinoid system: a general view and latest additions. Br J Pharmacol 141: 765-774, 2004.
9. 1 subunit. J Biol Chem 276: 34594-34599, 2001.
10. Dworetzky SI, Boissard CG, Lum-Ragan JT, McKay MC, Post-Munson DJ, Trojnacki JT, Chang CP, and Gribkoff VK. Phenotypic alteration of a human BK (hSlo) channel by hSloβ subunit coexpression: changes in blocker sensitivity, activation/relaxation and inactivation kinetics, and protein kinase A modulation. J Neurosci 16: 4543-4550, 1996.
11. Erxleben C, Everhart AL, Romeo C, Florance H, Bauer MB, Alcorta DA, Rossie S, Shipston MJ, and Armstrong DL. Interacting effects of N-terminal variation and strex exon splicing on slo potassium channel regulation by calcium, phosphorylation, and oxidation. J Biol Chem 277: 27045-27052, 2002.
12. Fleming I, Schermer B, Popp R, and Busse R. Inhibition of the production of endothelium-derived hyperpolarizing factor by cannabinoid receptor agonists. Br J Pharmacol 126: 949-960, 1999.
13. ca channels expressed in human embryonic kidney 293 cells by epoxyeicosatrienoic acid. Mol Pharmacol 59: 16-23, 2001.
14. Giangiacomo KM, Kamassah A, Harris G, and McManus OB. Mechanism of maxi-K channel activation by dehydrosoyasaponin-I. J Gen Physiol 112: 485-501, 1998.
15. Gribkoff VK, Starrett JE Jr, Dworetzky SI, Hewawasam P, Boissard CG, Cook DA, Frantz SW, Heman K, Hibbard JR, Huston K, Johnson G, Krishnan BS, Kinney GG, Lombardo LA, Meanwell NA, Molinoff PB, Myers RA, Moon SL, Ortiz A, Pajor L, Pieschl RL, Post-Munson DJ, Signor LJ, Srinivas N, Taber MT, Thalody G, Trojnacki JT, Wiener H, Yeleswaram K, and Yeola SW. Targeting acute ischemic stroke with a calcium-sensitive opener of maxi-K potassium channels. Nat Med 7: 471-477, 2001.
16. + currents in isolated smooth muscle cells from sheep urethra. Am J Physiol Cell Physiol 279: C420-C428, 2000.
17. + channels. Proc Natl Acad Sci USA 100: 10488-10493, 2003.
18. Imaizumi Y, Muraki K, and Watanabe M. Ionic currents in single smooth muscle cells from the ureter of the guinea-pig. J Physiol 411: 131-159, 1989.
19. + channel α-subunit. Mol Pharmacol 62: 836-846, 2002.
20. Jacobsson SOP, Wallin T, and Fowler CJ. Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids: relative involvement of cannabinoid and vanilloid receptors. J Pharmacol Exp Ther 299: 951-959, 2001.
21. + channels in vascular smooth muscle cells. FEBS Lett 297: 24-28, 1992.
22. Knaus HG, Garcia-Calvo M, Kaczorowski GJ, and Garcia ML. Subunit composition of the high conductance calcium-activated potassium channel from smooth muscle, a representative of the mSlo and slowpoke family of potassium channels. J Biol Chem 269: 3921-3924, 1994.
23. Lawson K. Is there a role for potassium channel openers in neuronal ion channel disorders? Expert Opin Investig Drugs 9: 2269-2280, 2000.
24. 1-4 subunits in HEK293 cells. J Membr Biol 192: 141-148, 2003.
25. + channels in isolated rat coronary arterial myocytes. J Physiol 534: 651-667, 2001.
26. + channel TASK-1. EMBO J 20: 47-54, 2001.
27. 2+ in endothelial cells. Br J Pharmacol 126: 1593-1600, 1999.
28. 1 receptor activation does not prevent the toxicity of glutamate towards embryonic chick telencephalon primary cultures. Comp Biochem Physiol C Toxicol Pharmacol 136: 245-251, 2003.
29. Pinto JC, Potie F, Rice KC, Böring D, Johnson MR, Evans DM, Wilken GH, Cantrell CH, and Howlett AC. Cannabinoid receptor binding and agonist activity of amides and esters of arachidonic acid. Mol Pharmacol 46: 516-522, 1994.
30. Plane F, Holland M, Waldron GJ, Garland CJ, and Boyle JP. Evidence that anandamide and EDHF act via different mechanisms in rat isolated mesenteric arteries. Br J Pharmacol 121: 1509-1511, 1997.
31. Randall MD, Alexander SPH, Bennett T, Boyd EA, Fry JR, Gardiner SM, Kemp PA, McCulloch AI, and Kendall DA. An endogenous cannabinoid as an endothelium-derived vasorelaxant. Biochem Biophys Res Commun 229: 114-120, 1996.
32. Randall MD, Harris D, Kendall DA, and Ralevic V. Cardiovascular effects of cannabinoids. Pharmacol Ther 95: 191-202, 2002.
33. Randall MD and Kendall DA. Involvement of a cannabinoid in endothelium-derived hyperpolarizing factor-mediated coronary vasorelaxation. Eur J Pharmacol 335: 205-209, 1997.
34. Shanley LJ, O'Malley D, Irving AJ, Ashford ML, and Harvey J. Leptin inhibits epileptiform-like activity in rat hippocampal neurones via PI 3-kinase-driven activation of BK channels. J Physiol 545: 933-944, 2002.
35. Shieh CC, Coghlan M, Sullivan JP, and Gopalakrishnan M. Potassium channels: molecular defects, diseases, and therapeutic opportunities. Pharmacol Rev 52: 557-594, 2000.
36. + channel. J Biol Chem 275: 23211-23218, 2000.
37. Valverde MA, Rojas P, Amigo J, Cosmelli D, Orio P, Bahamonde MI, Mann GE, Vergara C, and Latorre R. Acute activation of Maxi-K channels (hSlo) by estradiol binding to the β subunit. Science 285: 1929-1931, 1999.
38. Varga K, Lake KD, Huangfu D, Guyenet PG, and Kunos G. Mechanism of the hypotensive action of anandamide in anesthetized rats. Hypertension 28: 682-686, 1996.
39. 1 cannabinoid receptors in haemorrhagic shock. Nature 390: 518-521, 1997.
40. + channels: an additional transmembrane region at the N terminus. Proc Natl Acad Sci USA 93: 14922-14927, 1996.
41. Watanabe H, Vriens J, Prenen J, Droogmans G, Voets T, and Nilius B. Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels. Nature 424: 434-438, 2003.
42. White R and Hiley CR. A comparison of EDHF-mediated and anandamide-induced relaxations in the rat isolated mesenteric artery. Br J Pharmacol 122: 1573-1584, 1997.
43. White R, Ho WSV, Bottrill FE, Ford WR, and Hiley CR. Mechanisms of anandamide-induced vasorelaxation in rat isolated coronary arteries. Br J Pharmacol 134: 921-929, 2001.
44. 2+- and voltage-dependent BK channels in adrenal chromaffin cells and rat insulinoma tumor cells. J Neurosci 19: 5255-5264, 1999.
45. + channels in HEK293 cells. Jpn J Pharmacol 86: 342-350, 2001.
46. + channels by nordihydroguaiaretic acid. Jpn J Pharmacol 89: 53-63, 2002.
47. 2 receptor linked to phospholipase C in calf pulmonary endothelial cells. Br J Pharmacol 140: 1351-1362, 2003.
48. Zygmunt PM, Högestätt ED, Waldeck K, Edwards G, Kirkup AJ, and Weston AH. Studies on the effects of anandamide in rat hepatic artery. Br J Pharmacol 122: 1679-1686, 1997.
49. Zygmunt PM, Petersson J, Andersson DA, Chuang HH, Sørgård M, Di Marzo V, Julius D, and Högestätt ED. Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide. Nature 400: 452-457, 1999.